| #141 |
Nanjing Zhang |
Ptc Therapeutics |
1 |
| #141 |
Nathalie de Leon |
Harvard University |
1 |
| #141 |
Wen Xia |
Nec |
1 |
| #141 |
Frank Sebastian Castellano |
Basf Se |
1 |
| #141 |
Jonathan Michael Smith |
— |
1 |
| #141 |
Lauren Ciemnolonski |
Church & Dwight Co. |
1 |
| #141 |
Mohana K. Viswanathan |
Bank of America |
1 |
| #141 |
Prabhakar Konatham |
Sun Pharmaceutical Industries Limited |
1 |
| #141 |
Mohammad Ibrahim Qureshi |
Rive Technology |
1 |
| #141 |
Abdul Gaffar |
Colgate-Palmolive |
1 |
| #141 |
Michael Pope |
Princeton University |
1 |
| #141 |
David Berko |
Unknown |
1 |
| #141 |
Thomas M. McGuire |
Adlens Beacon |
1 |
| #141 |
Christian Theriault |
— |
1 |
| #141 |
Lory Bradley |
Medi-Physics |
1 |
| #141 |
Joshua Ghaim |
Mcneil-Ppc |
1 |
| #141 |
Harold Vincent Poor |
Princeton University |
1 |
| #141 |
Richard L. Lehman |
R.J. Reynolds Tobacco |
1 |
| #141 |
Marsha Smith |
Merck |
1 |
| #141 |
Jeffrey T. Bien |
Bristol-Myers Squibb |
1 |
| #141 |
Janak Singh |
Bristol-Myers Squibb |
1 |
| #141 |
Zhengxiang Gu |
Bristol-Myers Squibb |
1 |
| #141 |
James G. Reisman |
Siemens Aktiengesellschaft |
1 |
| #141 |
Garo Khanarian |
Hoechst Celanese |
1 |
| #141 |
Bryon Simmons |
Merck |
1 |
| #141 |
Jennifer Lynn Rexford |
AT&T |
1 |
| #141 |
Abraar Hussain |
AT&T |
1 |
| #141 |
Ohad Fried |
Solaredge Technologies |
1 |
| #141 |
John A. Grosso |
Bristol-Myers Squibb |
1 |
| #141 |
Peter I. Ravikovitch |
ExxonMobil |
1 |
| #141 |
Steven Hubert |
Synthetic Biologics |
1 |
| #141 |
Ryan Kelly |
Google |
1 |
| #141 |
Jeffrey Zahn |
Rutgers, The State University Of New Jersey |
1 |
| #141 |
Katherine S. Chiang |
Princeton University |
1 |
| #141 |
Christodoulos A. Floudas |
Princeton University |
1 |
| #141 |
Robert H. Austin |
Princeton University |
1 |
| #141 |
Ruifeng Sun |
Silicon Laboratories |
1 |
| #141 |
Eric Zhang |
IBM |
1 |
| #141 |
Kumar Ramaswamy |
Thomson Licensing |
1 |
| #141 |
Raul Rabadan |
Columbia University |
1 |
| #141 |
Marcus Hultmark |
Princeton University |
1 |
| #141 |
A. James Link |
— |
1 |
| #141 |
Alexander T. Kozhich |
Bristol-Myers Squibb |
1 |
| #141 |
David I. August |
Princeton University |
1 |
| #141 |
Jean-Valery Martin |
Innophos |
1 |
| #141 |
Kyle T. Tarantino |
Johnson & Johnson |
1 |
| #141 |
Vijay Nara |
Thomson Reuters (Markets) |
1 |
| #141 |
Siva Rama K. Nutalapati |
Aptapharma |
1 |
| #141 |
Oitak Allen Wong |
Saladax Biomedical |
1 |
| #141 |
John D. DiMarco |
Bristol-Myers Squibb |
1 |